The blood-based test could speed development of anti-tau treatments for Alzheimer’s, since drug developers can fairly quickly determine whether a compound they are testing is having any effect ...

Health New blood test diagnoses Alzheimer’s disease and measures how far it's progressed This is the first blood test to measure levels of tau, a protein linked to later stages of dementia ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known ...

VeraBIND Tau is designed for use in both symptomatic and presymptomatic patients, enabling earlier diagnosis when intervention is most effective. "Detecting tauopathy early gives patients and ...

AUSTIN, Texas, April 22, 2025 /PRNewswire/ -- Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBIND™ Tau, the first blood-based test designed ...

“This blood test clearly identifies Alzheimer’s tau tangles, which is our best biomarker measure of Alzheimer’s symptoms and dementia,” co-senior author Dr. Randall Bateman, a professor of ...

A groundbreaking study from Washington University School of Medicine in St. Louis and Lund University in Sweden has ...

“This blood test clearly identifies Alzheimer’s tau tangles, which is our best biomarker measure of Alzheimer’s symptoms and dementia,” co-senior author Randall J. Bateman, MD, said in a ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag ...

New non-invasive test offers 96% sensitivity and 90% specificity, empowering earlier and more accessible Alzheimer's detection AUSTIN, Texas, April 22, 2025 /PRNewswire/ -- Veravas, a leader in ...

Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBIND™ Tau, the first blood-based test designed to aid in the detection of Alzheimer's ...